Literature DB >> 10896315

Pharmacophore modelling of structurally unusual diltiazem mimics at L-type calcium channels.

K J Schleifer1, E Tot.   

Abstract

The purpose of this theoretical study was to investigate the molecular features of some structurally unusual calcium antagonists with experimentally proved affinity to the diltiazem-binding site at L-type calcium channels. Therefore, sterical and electronic characteristics of cis-/trans-diclofurime, the verapamil-like derivatives McN-5691 and McN-6186 as well as the natural products papaverine, laudanosine, antioquine and tetrandrine were compared with the pharmacophoric requirements detected for classical diltiazem-like derivatives. This yielded a common pharmacophore model for all of these compounds. Based on this model, one single negative molecular electrostatic potential induced by the free electron pairs of the oxime oxygen of trans-diclofurime was detected that might be responsible for the stronger effects compared to the cis isomer. Furthermore, the dual diltiazem- and verapamil-like features of McN-5691 (and McN-6186) as well as the distinct pharmacophoric assignment of the laudanosine enantiomers may be interpreted on a molecular level. Finally, the crucial partial structure of the bis-benzylisoquinoline derivatives antioquine and tetrandrine being responsible for the calcium antagonistic effects could be revealed by superposition on the most active benzothiazepinone derivative 8-methoxydiltiazem. The results obtained for these unusual diltiazem mimics are discussed taking into consideration earlier findings for classical diltiazem-like derivatives.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896315     DOI: 10.1023/a:1008188505899

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  20 in total

1.  Selective inhibition of calcium entry induced by benzylisoquinolines in rat smooth muscle.

Authors:  E Anselmi; G Fayos; R Blasco; L Candenas; D Cortes; P D'Ocon
Journal:  J Pharm Pharmacol       Date:  1992-04       Impact factor: 3.765

2.  Molecular modeling study of diltiazem mimics at L-type calcium channels.

Authors:  K J Schleifer; E Tot
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

3.  Conformational energy penalties of protein-bound ligands.

Authors:  J Boström; P O Norrby; T Liljefors
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

Review 4.  Structural basis of drug binding to L Ca2+ channels.

Authors:  J Striessnig; M Grabner; J Mitterdorfer; S Hering; M J Sinnegger; H Glossmann
Journal:  Trends Pharmacol Sci       Date:  1998-03       Impact factor: 14.819

5.  Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.

Authors:  D Rampe; A Skattebøl; D J Triggle; A M Brown
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

6.  Pyrrolo[2,1-c][1,4]benzothiazines: synthesis, structure-activity relationships, molecular modeling studies, and cardiovascular activity.

Authors:  G Campiani; A Garofalo; I Fiorini; M Botta; V Nacci; A Tafi; A Chiarini; R Budriesi; G Bruni; M R Romeo
Journal:  J Med Chem       Date:  1995-10-27       Impact factor: 7.446

7.  Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.

Authors:  D M Floyd; S D Kimball; J Krapcho; J Das; C F Turk; R V Moquin; M W Lago; K J Duff; V G Lee; R E White
Journal:  J Med Chem       Date:  1992-02-21       Impact factor: 7.446

8.  Tetrandrine: a novel calcium channel antagonist inhibits type I calcium channels in neuroblastoma cells.

Authors:  Q Y Liu; E Karpinski; M R Rao; P K Pang
Journal:  Neuropharmacology       Date:  1991-12       Impact factor: 5.250

9.  Selective action of two aporphines at alpha 1-adrenoceptors and potential-operated Ca2+ channels.

Authors:  M D Ivorra; S Chuliá; C Lugnier; M P D'Ocon
Journal:  Eur J Pharmacol       Date:  1993-02-09       Impact factor: 4.432

10.  Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.

Authors:  S D Kimball; D M Floyd; J Das; J T Hunt; J Krapcho; G Rovnyak; K J Duff; V G Lee; R V Moquin; C F Turk
Journal:  J Med Chem       Date:  1992-02-21       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.